Krka Sued over Patent Infringement in Denmark
Novo mesto, 11 April - Two subsidiaries of drugs giant AstraZeneca have filed a motion at a Copenhagen court seeking EUR 9.6m from the Swedish subsidiary of Slovenian drug maker Krka, Krka Sverige, over alleged infringement of a patent on the active substance esomperazole.
The rest of this news item is available to subscribers.
The news item consists of 527 characters (without spaces) or 97 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.